A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel

References

• Jin RC, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation 2005; 12(3)247–258
   PubMed Web of Science ®Google Scholar
• Arora R, Rai F. Atherothrombosis and the management of the vulnerable vascular patient. Am J Ther 2009; 16(1)24–34
   PubMed Web of Science ®Google Scholar
• Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16(1)1–20
   PubMed Web of Science ®Google Scholar
• Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin “resistance”. J Am Coll Cardiol 2009; 53(8)667–677
   PubMed Web of Science ®Google Scholar
• Cuisset T, Frere C, Poyet R, Quilici J, Gaborit B, Bali L, Brissy O, Lambert M, Morange PE, Alessi MC, et al. Clopidogrel response: Head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting. Arch Cardiovasc Dis 2010; 103(1)39–45
   PubMed Web of Science ®Google Scholar
• Hofer CK, Zollinger A, Ganter MT. Perioperative assessment of platelet function in patients under antiplatelet therapy. Expert Rev Med Devices 2010; 7(5)625–637
   PubMed Web of Science ®Google Scholar
• Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, Deneer VH, Harmsze AM, van der Heyden JA, Rensing BJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010; 303(8)754–762
   PubMed Web of Science ®Google Scholar
• Nicholson NS, Panzer-Knodle SG, Haas NF, Taite BB, Szalony JA, Page JD, Feigen LP, Lansky DM, Salyers AK. Assessment of platelet function assays. Am Heart J 1998; 135(5 Pt. 2 Su)S170–S178
   Web of Science ®Google Scholar
• Simon DI, Liu CB, Ganz P, Kirshenbaum JM, Piana RN, Rogers C, Selwyn AP, Popma JJ. A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban. Catheter Cardiovasc Interv 2001; 52(4)425–432
   PubMed Web of Science ®Google Scholar
• van Werkum JW, Hackeng CM, de Korte FI, Verheugt FW, Ten Berg JM. Point-of-care platelet function testing in patients undergoing PCI: Between a rock and a hard place. Neth Heart J 2007; 15(9)299–305
   PubMed Web of Science ®Google Scholar
• Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353(22)2373–2383
   PubMed Web of Science ®Google Scholar
• Herbert JM, Savi P. P2Y12, a new platelet ADP receptor, target of clopidogrel. Semin Vasc Med 2003; 3(2)113–122
   PubMedGoogle Scholar
• Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schomig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008; 99(1)121–126
   PubMed Web of Science ®Google Scholar
• Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 2000; 83(2)316–321
   PubMed Web of Science ®Google Scholar
• Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer–PFA-100. Semin Thromb Hemost 1995; 21(Suppl. 2)106–112
   PubMed Web of Science ®Google Scholar
• Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ. PFA-100 system: A new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24(2)195–202
   PubMed Web of Science ®Google Scholar
• Jakubowski JA, Payne CD, Li YG, Brandt JT, Small DS, Farid NA, Salazar DE, Winters KJ. The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration. Thromb Haemost 2008; 99(2)409–415
   PubMed Web of Science ®Google Scholar
• Karon BS, Wockenfus A, Scott R, Hartman SJ, McConnell JP, Santrach PJ, Jaffe AS. Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clin Chem 2008; 54(6)1060–1065
   PubMed Web of Science ®Google Scholar
• Chanarin I. Platelet function test. Laboratory haematology: An account of laboratory techniques, I Chanarin. Churchill Livingstone, Edinburgh 1989; 371–399
   Google Scholar
• Siller-Matula JM, Gouya G, Wolzt M, Jilma B. Cross validation of the multiple electrode aggregometry. A prospective trial in healthy volunteers. Thromb Haemost 2009; 102(2)397–403
   PubMed Web of Science ®Google Scholar
• Lordkipanidze M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007; 28(14)1702–1728
   PubMed Web of Science ®Google Scholar